RecruitingNCT04755855

Prospective Sinonasal Cancer Multi-institution Study

Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life

Sponsor

Mayo Clinic

Enrollment

200 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Sinonasal Carcinoma

Summary

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Eligibility

Min Age: 30 DaysMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with sinonasal carcinoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Days to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.